Patent ID: 11878016
Assignee: NEURIM PHARMACEUTICALS (1991) LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 27:
28. A method of treating a subject diagnosed with an intellectual disability, irritability, aggression, self-injurious behavior, hyperactivity, inattention, Fragile X syndrome, or diagnosed with elevated TNFα, or diagnosed with elevated inflammatory cytokine marker of neuroinflammation comprising administering ticagrelor, an enantiomer thereof, or a pharmaceutically acceptable salt thereof to the subject or administering a combination of ticagrelor, an enantiomer thereof, or a pharmaceutically acceptable salt thereof with a second agent in a weight ratio of 1:0.1 to 1:50 to the subject, wherein the second agent is selected from the group consisting of a magnesium ion containing-compound, a zinc ion containing-compound, L-lysine or a salt thereof, L-arginine or a salt thereof, lecithin, or a combination thereof.